It's experimental, but researchers are excited about a new vaccine that appears to prevent cervical cancer.
In the study of more than 500 women, the vaccine called "Gardasil" cut the rate of infection by 90%. The vaccine, made by Merck, works by preventing infection of four types of the human papilloma virus, which is blamed for the majority of cervical cancers.
An estimated 10,000 women will be diagnosed with cervical cancer this year, according to the American Cancer Society.